Safety and Effectiveness of Naproxen 220 mg + Paracetamol 300 mg + Pamabrom 25 mg Fixed Dose Combination in Women with Premenstrual Syndrome: A Post-Marketing, Open-Label, Uncontrolled, Prospective, Multicenter, Observational Study

Safety and Effectiveness of Naproxen 220 mg + Paracetamol 300 mg + Pamabrom 25 mg Fixed Dose Combination in Women with Premenstrual Syndrome: A Post-Marketing, Open-Label, Uncontrolled, Prospective, Multicenter, Observational Study

Premenstrual syndrome is characterized by pain and related symptoms that negatively affect women’s quality of life. Our aim was to evaluate the safety and effectiveness of a specific oral fixed dose combination of naproxen 220 mg + paracetamol 300 mg + pamabrom 25 mg in tablet form. A prospective, o...

Full description

Bibliographic Details
Main Authors: Álvaro E. Peña-Jiménez, Omar Benitez-Aguilar, Jesús E. Villegas, Mario González-de la-Parra, Livan Delgado-Roche
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Women
Subjects:
pain
nonsteroidal anti-inflammatory drugs
dysmenorrhea
edema
inflammation
over-the-counter drugs
Online Access:https://www.mdpi.com/2673-4184/4/1/2

Internet

https://www.mdpi.com/2673-4184/4/1/2

Similar Items